Sugimoto, Toshitsugu <br/><br/>
Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial.  [electronic resource] 

 -  Current medical research and opinion  Mar 2013 
 - 195-203 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2012.761956  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Calcium--administration & dosage<br/>Dietary Supplements<br/>Diphosphonates--therapeutic use<br/>Female<br/>Follow-Up Studies<br/>Fractures, Bone--prevention & control<br/>Hip--physiology<br/>Humans<br/>Male<br/>Osteoporosis--drug therapy<br/>Placebos<br/>Risk<br/>Spinal Fractures--prevention & control<br/>Spinal Injuries<br/>Spine--physiology<br/>Teriparatide--administration & dosage<br/>Vitamin D--administration & dosage